Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid: a novel conformationally restricted glutamic acid analogue

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid : a novel conformationally restricted glutamic acid analogue. / Bunch, Lennart; Liljefors, Tommy; Greenwood, Jeremy R; Frydenvang, Karla Andrea; Bräuner-Osborne, Hans; Krogsgaard-Larsen, Povl; Madsen, Ulf.

In: Journal of Organic Chemistry, Vol. 68, No. 4, 2003, p. 1489-95.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Bunch, L, Liljefors, T, Greenwood, JR, Frydenvang, KA, Bräuner-Osborne, H, Krogsgaard-Larsen, P & Madsen, U 2003, 'Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid: a novel conformationally restricted glutamic acid analogue', Journal of Organic Chemistry, vol. 68, no. 4, pp. 1489-95. https://doi.org/10.1021/jo026509p

APA

Bunch, L., Liljefors, T., Greenwood, J. R., Frydenvang, K. A., Bräuner-Osborne, H., Krogsgaard-Larsen, P., & Madsen, U. (2003). Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid: a novel conformationally restricted glutamic acid analogue. Journal of Organic Chemistry, 68(4), 1489-95. https://doi.org/10.1021/jo026509p

Vancouver

Bunch L, Liljefors T, Greenwood JR, Frydenvang KA, Bräuner-Osborne H, Krogsgaard-Larsen P et al. Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid: a novel conformationally restricted glutamic acid analogue. Journal of Organic Chemistry. 2003;68(4):1489-95. https://doi.org/10.1021/jo026509p

Author

Bunch, Lennart ; Liljefors, Tommy ; Greenwood, Jeremy R ; Frydenvang, Karla Andrea ; Bräuner-Osborne, Hans ; Krogsgaard-Larsen, Povl ; Madsen, Ulf. / Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid : a novel conformationally restricted glutamic acid analogue. In: Journal of Organic Chemistry. 2003 ; Vol. 68, No. 4. pp. 1489-95.

Bibtex

@article{2eed125afa49401c80296be95aea9ab2,
title = "Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid: a novel conformationally restricted glutamic acid analogue",
abstract = "The design and synthesis of conformationally restricted analogues of alpha-amino acids is an often used strategy in medicinal chemistry research. Here we present the rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid (1), a novel conformationally restricted (S)-glutamic acid (Glu) analogue intended as a mimic of the folded Glu conformation. The synthesis of 1 was completed in its racemic form in eight steps from commercially available starting materials. As a key step, the first facially selective hydroboration of a 5-methylidene[2.2.1]bicyclic intermediate was investigated. In this transformation, the catalytic methodology of Wilkinson's/catechol borane proved superior to stoichiometric borane or dialkyl borane reagents, in terms of higher diastereomeric excess and chemical yield. To our surprise (+/-)-1 did not show affinity in binding studies on native 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) (IC(50) > 300 microM, [(3)H]AMPA) or kainic acid (IC(50) > 160 microM, [(3)H]kainic acid) receptors nor in binding studies on the cloned iGluR5,6 subtypes (IC(50) > 300 microM, [(3)H]kainic acid).",
keywords = "Aza Compounds, Dicarboxylic Acids, Glutamic Acid, Inhibitory Concentration 50, Kainic Acid, Magnetic Resonance Spectroscopy, Molecular Conformation, Molecular Mimicry, Molecular Structure, Norbornanes, Receptors, Glutamate, Stereoisomerism, Structure-Activity Relationship, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid",
author = "Lennart Bunch and Tommy Liljefors and Greenwood, {Jeremy R} and Frydenvang, {Karla Andrea} and Hans Br{\"a}uner-Osborne and Povl Krogsgaard-Larsen and Ulf Madsen",
year = "2003",
doi = "10.1021/jo026509p",
language = "English",
volume = "68",
pages = "1489--95",
journal = "Journal of Organic Chemistry",
issn = "0022-3263",
publisher = "American Chemical Society",
number = "4",

}

RIS

TY - JOUR

T1 - Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid

T2 - a novel conformationally restricted glutamic acid analogue

AU - Bunch, Lennart

AU - Liljefors, Tommy

AU - Greenwood, Jeremy R

AU - Frydenvang, Karla Andrea

AU - Bräuner-Osborne, Hans

AU - Krogsgaard-Larsen, Povl

AU - Madsen, Ulf

PY - 2003

Y1 - 2003

N2 - The design and synthesis of conformationally restricted analogues of alpha-amino acids is an often used strategy in medicinal chemistry research. Here we present the rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid (1), a novel conformationally restricted (S)-glutamic acid (Glu) analogue intended as a mimic of the folded Glu conformation. The synthesis of 1 was completed in its racemic form in eight steps from commercially available starting materials. As a key step, the first facially selective hydroboration of a 5-methylidene[2.2.1]bicyclic intermediate was investigated. In this transformation, the catalytic methodology of Wilkinson's/catechol borane proved superior to stoichiometric borane or dialkyl borane reagents, in terms of higher diastereomeric excess and chemical yield. To our surprise (+/-)-1 did not show affinity in binding studies on native 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) (IC(50) > 300 microM, [(3)H]AMPA) or kainic acid (IC(50) > 160 microM, [(3)H]kainic acid) receptors nor in binding studies on the cloned iGluR5,6 subtypes (IC(50) > 300 microM, [(3)H]kainic acid).

AB - The design and synthesis of conformationally restricted analogues of alpha-amino acids is an often used strategy in medicinal chemistry research. Here we present the rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid (1), a novel conformationally restricted (S)-glutamic acid (Glu) analogue intended as a mimic of the folded Glu conformation. The synthesis of 1 was completed in its racemic form in eight steps from commercially available starting materials. As a key step, the first facially selective hydroboration of a 5-methylidene[2.2.1]bicyclic intermediate was investigated. In this transformation, the catalytic methodology of Wilkinson's/catechol borane proved superior to stoichiometric borane or dialkyl borane reagents, in terms of higher diastereomeric excess and chemical yield. To our surprise (+/-)-1 did not show affinity in binding studies on native 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) (IC(50) > 300 microM, [(3)H]AMPA) or kainic acid (IC(50) > 160 microM, [(3)H]kainic acid) receptors nor in binding studies on the cloned iGluR5,6 subtypes (IC(50) > 300 microM, [(3)H]kainic acid).

KW - Aza Compounds

KW - Dicarboxylic Acids

KW - Glutamic Acid

KW - Inhibitory Concentration 50

KW - Kainic Acid

KW - Magnetic Resonance Spectroscopy

KW - Molecular Conformation

KW - Molecular Mimicry

KW - Molecular Structure

KW - Norbornanes

KW - Receptors, Glutamate

KW - Stereoisomerism

KW - Structure-Activity Relationship

KW - alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid

U2 - 10.1021/jo026509p

DO - 10.1021/jo026509p

M3 - Journal article

C2 - 12585893

VL - 68

SP - 1489

EP - 1495

JO - Journal of Organic Chemistry

JF - Journal of Organic Chemistry

SN - 0022-3263

IS - 4

ER -

ID: 40371578